SUV Max as Predictor of Outcome in Cervical Cancer

A Study to Evaluate the Value of SUV-Max in PET-FDG in Predicting Outcome of Surgery Vis a Vis Need for Radiotherapy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01262144

Enrollment

Registered

2010-12-17

Start date

2010-08-31

Completion date

Unknown

Last updated

2010-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Keywords

Cervical Cancer, PET CT, SUV Max

Brief summary

Cervical Cancer is staged clinically, not surgically. Patients in whom an extensive disease is identified are not usually eligible for surgery. PET-CT is used to support staging. However, some patients received surgery after staging and subsequently require radio/chemotherapy due to findings on operation. This study will attempt to find a correlation between SUV-Max on PET-CT and subsequent outcomes i.e. need for adjuvant therapy.

Interventions

RADIATIONRadiotherapy

Radiotherapy for cervical cancer

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* having stating PET-CT stored on site * treated with surgery

Exclusion criteria

* not eligible for surgery based on PET-CT, clinical stage

Design outcomes

Primary

Measure	Time frame
Administration of adjuvant therapy	immediately following surgery

Secondary

Measure	Time frame
Overall survival	surgery - present day

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026